Delivery Order SPE2DB25D7067-SPE2DB25FSUHR

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,301.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a period of performance through March 10, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,257.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $5,187.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a total potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,290.04, is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,013.00 firm fixed-price delivery order is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has an ultimate completion date of November 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,257.60 firm fixed price contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM medical products. The contract has a completion date of February 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has a ceiling value of $1,063.73 and a completion date of August 6, 2024. It is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,045.51, is a delivery order to supply PROCTOFOAM-HC 1%-1% FOAM 10GM medical products. The contract has a ceiling value of $3,045.51 and a completion date of November 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,279.49, is a Delivery Order for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has an ultimate completion date of January 30, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $4,862.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a completion date of November 13, 2024. The award is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB25D7067
    Indefinite Delivery Contract
  • SPE2DB25D7067-SPE2DB25FSUHR
    Delivery Order

This federal contract award, valued at $1,467.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a completion date of January 16, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no subcontractors are mentioned. The contract supports the DLA's mission of providing essential medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 4/17/25, 8:40 AM